Healthcare Global Enterprises Ltd
NSE:HCG
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
315.2
474.65
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Healthcare Global Enterprises Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | IN |
Market Cap | 65.2B INR |
Net Margin |
3%
|
Country | US |
Market Cap | 83.9B USD |
Net Margin |
9%
|
Country | SA |
Market Cap | 98B SAR |
Net Margin |
22%
|
Country | ZA |
Market Cap | 24.9B Zac |
Net Margin |
17%
|
Country | ZA |
Market Cap | 20.7B Zac |
Net Margin |
5%
|
Country | CN |
Market Cap | 133.2B CNY |
Net Margin |
18%
|
Country | MY |
Market Cap | 63.3B MYR |
Net Margin |
11%
|
Country | US |
Market Cap | 13.7B USD |
Net Margin |
15%
|
Country | US |
Market Cap | 13.1B USD |
Net Margin |
7%
|
Country | TH |
Market Cap | 421.1B THB |
Net Margin |
15%
|
Country | IN |
Market Cap | 997.2B INR |
Net Margin |
5%
|
Healthcare Global Enterprises Ltd
Glance View
HealthCare Global Enterprises Ltd. provides imaging and diagnostics services for cancer treatment. The company is headquartered in Bangalore, Karnataka. The company went IPO on 2016-03-30. The firm is involved retail sale of pharmaceuticals, medical and orthopedic goods and toilet articles. The company operates cancer care network under the HCG brand. The company operates infertility treatment clinics providing assisted reproductive services under brand Milann. The firm operates eight Milann fertility centers, which provide reproductive medicine services, including assisted reproduction, gynecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment. Milann fertility centers also offer training programs for fertility specialists and embryologists. Under the Triesta brand, it provides clinical reference laboratory services with specialization in oncology.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Healthcare Global Enterprises Ltd's most recent financial statements, the company has Net Margin of 2.7%.